Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.
Production of infectious hepatitis C virus in cell culture has become possible because of the unique properties of the JFH1 isolate. However, virus titers are rather low, limiting the utility of this system. Here we describe the generation of cell culture-adapted JFH1 variants yielding higher titers of infectious particles and enhanced spread of infection in cultured cells. Sequence analysis of adapted genomes revealed a complex pattern of mutations that differed in two independent experiments. Adaptive mutations were observed both in the structural and in the nonstructural regions, with the latter having the highest impact on enhancement of virus titers. The major adaptive mutation was identified in NS5A, and it enhanced titers of three intergenotypic chimeras consisting of the structural region of a genotype 1a, 1b, or 3a isolate and the remainder of the JFH1 isolate. The mutation resides at the P3 position of the NS5A-B cleavage site and slows down processing, implying that subtle differences in replication complex formation appear to determine the efficiency of virus formation. Highly adapted JFH1 viruses carrying six mutations established a robust infection in uPA-transgenic SCID mice xenografted with human hepatocytes. However, the mutation in NS5A which enhanced virus titers in cell culture the most had reverted to wild type in nearly half of the viral genomes isolated from these animals at 15 weeks postinoculation. These results argue for some level of impaired fitness of this mutant in vivo.
Kaul
Artur
A
Department of Molecular Virology, University of Heidelberg, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany.
Woerz
Ilka
I
Meuleman
Philip
P
Leroux-Roels
Geert
G
Bartenschlager
Ralf
R
D000220:Adaptation, Biological / Q000235:genetics*; D000818:Animals; D002460:Cell Line; D004252:DNA Mutational Analysis; D016679:Genome, Viral / Q000235:genetics; D016174:Hepacivirus / Q000235:genetics* / Q000254:growth & development / Q000502:physiology*; D006526:Hepatitis C / Q000821:virology; D051379:Mice; D016513:Mice, SCID; D008822:Mice, Transgenic; D050296:Microbial Viability; D020125:Mutation, Missense; D017361:Viral Nonstructural Proteins / Q000235:genetics; D015678:Viral Structural Proteins / Q000235:genetics; D014776:Virus Cultivation
D017361:Viral Nonstructural Proteins; D015678:Viral Structural Proteins